|
 | Up a level |
Colomer-Carbonell, Ariadna, Sanabria-Mazo, Juan P., Hernández-Negrín, Halbert, Borràs, Xavier, Suso-Ribera, Carlos, Garciá-Palacios, Azucena, Muchart, Jordi, Munuera, Josep, D'Amico, Francesco, Maes, Michael, Younger, Jarred W., Feliu-Soler, Albert, Rozadilla-Sacanell, Antoni and Luciano, Juan V. (2022) Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study). BMJ Open, 12 (1). ISSN 2044-6055
Sanabria-Mazo, Juan P., Forero, Carlos G., Cristobal-Narváez, Paula, Suso-Ribera, Carlos, García-Palacios, Azucena, Colomer-Carbonell, Ariadna, Pérez-Aranda, Adrián, Andrés-Rodríguez, Laura, McCracken, Lance M., D'Amico, Francesco, Estivill-Rodríguez, Pere, Carreras-Marcos, Bernat, Montes-Pérez, Antonio, Comps-Vicente, Olga, Esteve, Montserrat, Grasa, Mar, Rosa, Araceli, Cuesta-Vargas, Antonio I., Maes, Michael, Borràs, Xavier, Edo, Silvia, Sanz, Antoni, Feliu-Soler, Albert, Castaño-Asins, Juan R. and Luciano, Juan V. (2020) Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression: study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study). BMJ Open, 10 (7). ISSN 2044-6055
